| UNIQURE N.V. EO -,05 |
| Niederlande |
| Gesundheit |
| NL0010696654 / A1XDTV |
| UQ1 (Frankfurt) / QURE (NASDAQ) |
| FRA:UQ1, ETR:UQ1, UQ1:GR, NASDAQ:QURE |
| - |
| https://www.uniqure.com/ |
|
uniQure N.V. is a biopharmaceutical company based in the Netherlands, specializing in the discovery, development, and commercialization of innovative gene therapies for patients with severe genetic and neurological disorders. It leverages a proprieta..
>Volltext.. |
| 917.43 Mio. EUR |
| 845.1 Mio. EUR |
| 13.79 Mio. EUR |
| -153.08 Mio. EUR |
| -170.39 Mio. EUR |
| -2.98 EUR |
| 459.53 Mio. EUR |
| 68.72 Mio. EUR |
| -157.18 Mio. EUR |
| 9.89 |
| -47.68% |
| 26.79% |
| - |
| - |
| - |
| - |
| UNIQURE |
| 10.04.26 |